Trial Profile
Comparative Retrospective Non-Randomized Pharmacoeconomic Trial of Efficiency and Safety of use of Paclitaxels (Paclitaxel-Lens or Taxol) in a Monomode for 2Nd Line of Treatment of Metastatic Breast Cancer Patients
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2011
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 14 Feb 2011 New trial record